A dual-round signal amplification strategy for colorimetric/photoacoustic/fluorescence triple read-out detection of prostate specific antigen

2020 ◽  
Vol 56 (36) ◽  
pp. 4942-4945 ◽  
Author(s):  
Chao Jiang ◽  
Yan Huang ◽  
Ting He ◽  
Peng Huang ◽  
Jing Lin

A colorimetric/fluorescence/photoacoustic triple read-out detection of prostate specific antigen (PSA) was developed by using a silica coated Au@Ag core–shell nanorod (denoted Au@Ag@SiO2) based enzyme-linked immunosorbent assay (ELISA) system.

2019 ◽  
Vol 43 (40) ◽  
pp. 15910-15914 ◽  
Author(s):  
Yan Wang ◽  
Lijuan Chen ◽  
Qingxia Wu ◽  
Zejun Wen ◽  
Yujing Ren ◽  
...  

A one-pot strategy for the preparation of all-in-one signal tags for the colorimetric immunoassay of prostate-specific antigen.


2019 ◽  
Author(s):  
Qian Chen ◽  
Tian Tian ◽  
Erhu Xiong ◽  
Po Wang ◽  
Xiaoming Zhou

ABSTRACTThe enzyme-linked immunosorbent assay (ELISA) is a basic technique used in analytical and clinical investigations. However, conventional ELISA is still not sensitive enough to detect ultra-low concentrations of biomarkers for the early diagnosis of cancer, cardiovascular risk, neurological disorders, and infectious diseases. Herein we show a mechanism utilizing the CRISPR/Cas13a-based signal export amplification strategy, which double-amplifies the output signal by T7 RNA polymerase transcription and CRISPR/Cas13a collateral cleavage activity. This process is termed the CRISPR/Cas13a signal amplification linked immunosorbent assay (CLISA). The proposed method was validated by detecting an inflammatory factor, human interleukin-6 (human IL-6), and a tumor marker, human vascular endothelial growth factor (human VEGF), which achieved limit of detection (LOD) values of 45.81 fg/mL (2.29 fM) and 32.27 fg/m (0.81 fM), respectively, demonstrating that CLISA is at least 102-fold more sensitive than conventional ELISA.


2019 ◽  
Vol 11 (44) ◽  
pp. 5661-5672 ◽  
Author(s):  
Mina Shaban ◽  
Mohammad Hasanzadeh ◽  
Elham Solhi

A novel sandwich-type biosensor based on a signal amplification strategy of various nanocomposites was developed to monitor the prostate-specific antigen (PSA) in real samples.


Urology ◽  
1999 ◽  
Vol 53 (1) ◽  
pp. 228-235 ◽  
Author(s):  
Senji Hoshi ◽  
Satsuki Kobayashi ◽  
Toshiko Takahashi ◽  
Ken-Ichi Suzuki ◽  
Sadafumi Kawamura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document